NCT03015272

Brief Summary

The goal of the Novel Language Intervention for minimally verbal children with Autism Spectrum Disorder (ASD) is to test the efficacy of one experimental treatment (AMMT) compared to baseline assessments and compare the AMMT efficacy to a control intervention (SRT), both treatments were designed to facilitate speech output in minimally verbal 5.5 to 12.0 year olds. This study aims to compare the two interventions (one intonation-based; the other non-intonation-based) in a single-blind, randomized controlled trial (RCT) that includes a comprehensive baseline assessment battery, 25 intensive 1-on-1 treatment sessions conducted 5 days/week, and a series of probe assessments administered at multiple timepoints pre-, during, and post-therapy. Despite the complex needs of minimally verbal children with ASD and the wide variety of treatments available to address many of those needs, there is still a great need for effective methods that promote the development of speech sounds and facilitate the production of those sounds in this growing population. While the primary aim of this RCT is to investigate the effects of AMMTversus a control intervention (SRT) on minimally verbal children with ASD and compare the two interventions to determine whether one is more effective than the other, this study also aims to examine whether baseline cognitive skills, speech praxis, joint attention abilities and/or neural architecture can predict the effects of treatment with AMMT or SRT in minimally verbal children with ASD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Nov 2014

Longer than P75 for phase_2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 29, 2016

Completed
12 months until next milestone

First Posted

Study publicly available on registry

January 10, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

4.8 years

First QC Date

January 29, 2016

Last Update Submit

May 15, 2020

Conditions

Keywords

minimally-verbalchildreninterventionsingingmusic

Outcome Measures

Primary Outcomes (1)

  • Change in approximately correct Consonant-Vowel Syllables between Best-Baseline and Post-25-session assessment

    Approximately correct consonant-vowel syllables of 30 target words/phrases (15 Trained; 15 Untrained) presented using visual clues during at least 3 baseline assessments, multiple interim assessments (after 10, 15, 20, 25 therapy sessions), and one post-treatment assessment (4 weeks after the end of therapy).

    ≥3 Baseline Assessments (over 1 week) after randomization and before therapy initiation; 4 assessments during and after therapy period (after 10, 15, 20, 25 sessions), and one follow-up assessment 4 weeks after the End of Therapy (total period 11 weeks)

Secondary Outcomes (1)

  • Change in approximately correct Consonant-Vowel Syllables between Best-Baseline and Post-4-week follow-up assessment

    ≥3 Baseline Assessments (over 1 week) after randomization and before therapy initiation; 4 assessments during and after therapy period (after 10, 15, 20, 25 sessions), and one follow-up assessment 4 weeks after the End of Therapy (total period 11 weeks)

Study Arms (2)

Auditory-Motor Mapping Training (AMMT)

EXPERIMENTAL

Auditory-Motor Mapping Training (AMMT) is a novel, intonation-based intervention that is accompanied by simultaneous tapping each spoken syllable on tuned drums designed to help minimally verbal children between the ages of 5.5 and 12 years develop and/or improve speech output. AMMT is administered 1-on-1 for 45 min./day, 5 days/week (25 sessions) by researchers trained in this intervention.

Behavioral: Auditory-Motor Mapping Training

Speech-Repetition Therapy (SRT)

ACTIVE COMPARATOR

Speech-Repetition-Therapy (SRT) is a novel, non-intonation-based intervention designed to help minimally verbal children between the ages of 5.5 and 12 years develop and/or improve speech output. SRT is administered 1-on-1 for 45 min./day, 5 days/week (25 sessions) by researchers trained in this intervention. SRT serves as a control intervention to AMMT

Behavioral: Speech-Repetition Therapy

Interventions

AMMT is a novel, intonation-based intervention that is accompanied by simultaneous tapping each spoken syllable on tuned drums, designed to help minimally verbal children between the ages of 5.5 and12.0 years develop and/or improve speech output. AMMT is administered 1-on-1 for 45 min./day, 5 days/week (25 sessions) by researchers trained in the method.

Also known as: AMMT
Auditory-Motor Mapping Training (AMMT)

SRT is a novel, non-intonation-based intervention designed to help minimally verbal children between the ages of 5.5 and 12 years develop and/or improve speech output. SRT is administered 1-on-1 for 45 min./day, 5 days/week (25 sessions) by researchers trained in this intervention. SRT serves as a control intervention to AMMT.

Also known as: SRT
Speech-Repetition Therapy (SRT)

Eligibility Criteria

Age66 Months - 120 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • be between the ages of 5;6 and 12;0 years,
  • have a diagnosis of ASD,
  • be classified as "minimally verbal" (which is defined as having fewer than 20 spoken words/phrases used for functional communication),
  • demonstrate minimal progress in speech acquisition despite having had at least 18 months of speech therapy,
  • have no other significant neurological or psychiatric illnesses/disorders other than ASD
  • have no major hearing impairment,
  • have a nonverbal mental age over 18 months,
  • be able to follow 1-step commands without prompting,
  • be able to sit in a chair for more than 15 minutes at a time, and
  • be able to imitate at least 2 speech sounds on command.
  • Families must agree to:
  • \- attend testing and treatment sessions at BIDMC 5 days/week for approx. 6-8 weeks,
  • \- attend pre- and post-intervention testing at BU's Autism Center of Excellence,
  • \- pre- and post-intervention MRI scanning at MGH's Martinos Center, and
  • \- video-recording of testing and treatment sessions.
  • +1 more criteria

You may not qualify if:

  • have a history of significant neurological or psychiatric disorder other than ASD that could interfere with this study as determined by PI;
  • have a major hearing impairment,
  • have a nonverbal mental age of less than 18 months,
  • have undergone a significant amount of intonation-based therapy (more than 25 sessions) within the 12 months period prior to enrollment,
  • are able to produce more 20 or more words used communicatively,
  • are unable to imitate at least 2 speech sounds on command,
  • cannot commit to pre- and post- intervention testing and MRI at BU and MGH,
  • cannot commit to 11 weeks of testing and treatment at BIDMC,
  • are not willing to be video-recorded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

Boston University, Autism Center of Excellence

Boston, Massachusetts, 02215, United States

Location

Related Publications (6)

  • Wan CY, Bazen L, Baars R, Libenson A, Zipse L, Zuk J, Norton A, Schlaug G. Auditory-motor mapping training as an intervention to facilitate speech output in non-verbal children with autism: a proof of concept study. PLoS One. 2011;6(9):e25505. doi: 10.1371/journal.pone.0025505. Epub 2011 Sep 29.

    PMID: 21980480BACKGROUND
  • Wan CY, Schlaug G. Neural pathways for language in autism: the potential for music-based treatments. Future Neurol. 2010 Nov;5(6):797-805. doi: 10.2217/fnl.10.55.

    PMID: 21197137BACKGROUND
  • Wan CY, Demaine K, Zipse L, Norton A, Schlaug G. From music making to speaking: engaging the mirror neuron system in autism. Brain Res Bull. 2010 May 31;82(3-4):161-8. doi: 10.1016/j.brainresbull.2010.04.010. Epub 2010 Apr 28.

    PMID: 20433906BACKGROUND
  • Kasari C, Brady N, Lord C, Tager-Flusberg H. Assessing the minimally verbal school-aged child with autism spectrum disorder. Autism Res. 2013 Dec;6(6):479-93. doi: 10.1002/aur.1334. Epub 2013 Oct 29.

    PMID: 24353165BACKGROUND
  • Tager-Flusberg H. Promoting communicative speech in minimally verbal children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):612-3. doi: 10.1016/j.jaac.2014.04.005. No abstract available.

    PMID: 24839879BACKGROUND
  • Chenausky K, Norton A, Tager-Flusberg H, Schlaug G. Auditory-Motor Mapping Training: Comparing the Effects of a Novel Speech Treatment to a Control Treatment for Minimally Verbal Children with Autism. PLoS One. 2016 Nov 9;11(11):e0164930. doi: 10.1371/journal.pone.0164930. eCollection 2016.

    PMID: 27829034BACKGROUND

Related Links

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Gottfried Schlaug, MD, PhD

    Beth Israel Deaconess Medical Center/Harvard Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurology

Study Record Dates

First Submitted

January 29, 2016

First Posted

January 10, 2017

Study Start

November 1, 2014

Primary Completion

September 1, 2019

Study Completion

December 1, 2019

Last Updated

May 19, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will share

Locations